Financials

  • Market Capitalization 4.31 B
  • Employee 137
  • Founded 2017
  • CEO N/A
  • Website www.tangotx.com
  • Headquarter Delaware, United States
  • FIGI BBG00WFDDRS0
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-25.2
Rapporto prezzo/fatturato
43.08

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1426
VKTX
Viking Therapeutics, Inc. - Common Stock
37.61 USD-0.95%-7.07%+27.49%+20.35%4.37 B USD
1436
ACAD
ACADIA Pharmaceuticals Inc. - Common Stock
25.43 USD-0.24%-3.27%+19.22%+15.17%4.35 B USD
1450
EWTX
Edgewise Therapeutics, Inc. - Common Stock
39.34 USD-0.98%-12.50%+10.17%+158.31%4.23 B USD
1529
NAMS
NewAmsterdam Pharma Company N.V. - Ordinary Shares
32.20 USD-3.27%-11.73%+5.40%-11.22%3.76 B USD

Notizie